Back
CBS PREMIUM ACCESS

Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification

Session: Poster Session 1
Topic: Valvular Heart Disease
Speaker: Doctor F. Bartoli-Leonard (Bristol, GB)
Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Francesca Bartoli-Leonard

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)
0 follower

73 more presentations in this session

Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients

Speaker: Miss E. Bevilacqua (Seville, ES)

Access
Abstract
Like
Thumbnail

Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring

Speaker: Doctor K. Viligorska (Chernivtsi, UA)

Access
Abstract
Like
Thumbnail

Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study

Speaker: Mr C. Rios Navarro (Valencia, ES)

Access
Abstract
Like
Thumbnail

Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion

Speaker: Associate Professor L. Tacu (Chisinau, MD)

Access
Abstract
Like
Thumbnail

Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets

Speaker: Doctor B. Agg (Budapest, HU)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1

Speakers: Doctor F. Bartoli-Leonard, Miss E. Bevilacqua, Doctor K. Viligorska, Mr C. Rios Navarro, Associate Professor L. Tacu...
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources